Authors : Gaurav Patel

Volume/Issue : Volume 11 - 2026, Issue 1 - January

Google Scholar : https://tinyurl.com/muaxtk6x

Scribd : https://tinyurl.com/vcpvrhe5

DOI : https://doi.org/10.38124/ijisrt/26jan1247

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Iontophoretic and transdermal drug delivery systems have emerged as promising non-invasive alternatives to conventional oral and parenteral routes, offering controlled drug administration, improved patient compliance, and reduced systemic side effects. However, the highly efficient barrier function of the skin, particularly the stratum corneum, limits the passive permeation of most therapeutic agents, including hydrophilic drugs and biologics. Recent advancements in physical enhancement technologies, such as iontophoresis, microneedles, and ultrasound-mediated delivery, have significantly expanded the scope of transdermal drug delivery by transiently and reversibly modulating skin permeability. Among these approaches, iontophoresis enables precise, on-demand drug delivery through electrical driving forces, facilitating the transport of charged and polar molecules across the skin. This review highlights recent progress in iontophoretic and advanced transdermal systems, focusing on underlying mechanisms, formulation design strategies, analytical evaluation techniques, and emerging clinical applications. Special emphasis is placed on localized drug delivery and the potential role of iontophoresis in anticancer therapy. Current challenges and future perspectives related to clinical translation and regulatory considerations are also discussed, underscoring the growing significance of these technologies in modern drug delivery and precision therapeutics.

Keywords : Iontophoresis; Transdermal Drug Delivery; Physical Enhancement Techniques; Microneedles; Sonophoresis; Biologics Delivery; Anticancer Therapy; Wearable Drug Delivery Systems.

References :

1. U. Detamornrat et al., ‘Transdermal on-demand drug delivery based on an iontophoretic hollow microneedle array system’, Lab Chip, vol. 23, no. 9, 2023, doi: 10.1039/d3lc00160a.
2. Q. Fan, K. K. Sirkar, and B. Michniak, ‘Iontophoretic transdermal drug delivery system using a conducting polymeric membrane’, J Memb Sci, vol. 321, no. 2, 2008, doi: 10.1016/j.memsci.2008.04.061.
3.        C. Wu et al., ‘Self-Powered Iontophoretic Transdermal Drug Delivery System Driven and Regulated by Biomechanical Motions’, Adv Funct Mater, vol. 30, no. 3, 2020, doi: 10.1002/adfm.201907378.
4. M. A. Bolzinger, S. Briançon, J. Pelletier, and Y. Chevalier, ‘Penetration of drugs through skin, a complex rate-controlling membrane’, Curr Opin Colloid Interface Sci, vol. 17, no. 3, pp. 156–165, 2012, doi: 10.1016/j.cocis.2012.02.001.
5. M. E. Lane, ‘Skin penetration enhancers’, Int J Pharm, vol. 447, no. 1–2, pp. 12–21, 2013, doi: 10.1016/j.ijpharm.2013.02.040.
6. [6]  X. Hu and H. He, ‘A review of cosmetic skin delivery’, 2021. doi: 10.1111/jocd.14037.
7. ‘CN104080438B - Skin-lightening cosmetic - Google Patents’. Accessed: Nov. 05, 2022. [Online]. Available: https://patents.google.com/patent/CN104080438B/en?q=kojic+acid+hplc&oq=kojic+acid+hplc
8. Z. Palac, A. Engesland, G. E. Flaten, N. Škalko-Basnet, J. Filipović-Grčić, and Ž. Vanić, ‘Liposomes for (trans)dermal drug delivery: The skin-PVPA as a novel in vitro stratum corneum model in formulation development’, J Liposome Res, vol. 24, no. 4, 2014, doi: 10.3109/08982104.2014.899368.
9. A. M. Helmy, ‘Overview of recent advancements in the iontophoretic drug delivery to various tissues and organs’, 2021. doi: 10.1016/j.jddst.2021.102332.
10. Y. Wang, L. Zeng, W. Song, and J. Liu, ‘Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress’, 2022. doi: 10.1007/s13346-021-00898-6.
11.        T. Gratieri, V. Santer, and Y. N. Kalia, ‘Basic principles and current status of transcorneal and transscleral iontophoresis’, 2017. doi: 10.1080/17425247.2017.1266334.
12. N. Patel, S. Jain, P. Madan, and S. Lin, ‘Application of design of experiments for formulation development and mechanistic evaluation of iontophoretic tacrine hydrochloride delivery’, Drug Dev Ind Pharm, vol. 42, no. 11, 2016, doi: 10.1080/03639045.2016.1181646.
13. L. Simon, J. Ospina, and K. Ita, ‘Prediction of in-vivo iontophoretic drug release data from in-vitro experiments-insights from modeling’, Math Biosci, vol. 270, 2015, doi: 10.1016/j.mbs.2015.10.011.
14. M. Parrilla, U. Detamornrat, J. Domínguez-Robles, S. Tunca, R. F. Donnelly, and K. De Wael, ‘Wearable Microneedle-Based Array Patches for Continuous Electrochemical Monitoring and Drug Delivery: Toward a Closed-Loop System for Methotrexate Treatment’, ACS Sens, vol. 8, no. 11, 2023, doi: 10.1021/acssensors.3c01381.
15.        L. Simon, A. N. Weltner, Y. Wang, and B. Michniak, ‘A parametric study of iontophoretic transdermal drug-delivery systems’, J Memb Sci, vol. 278, no. 1–2, 2006, doi: 10.1016/j.memsci.2005.10.049.
16. B. Olifirov et al., ‘Local Iontophoretic Application for Pharmacological Induction of Long-Term Synaptic Depression’, Bio Protoc, vol. 15, no. 11, 2025, doi: 10.21769/BioProtoc.5338.
17. I. Power, ‘Fentanyl HCl iontophoretic transdermal system (ITS): Clinical application of iontophoretic technology in the management of acute postoperative pain’, 2007. doi: 10.1093/bja/ael314.
18. V. K. Singh, A. Anis, S. M. Al-Zahrani, D. K. Pradhan, and K. Pal, ‘Molecular and electrochemical impedance spectroscopic characterization of the carbopol based bigel and its application in iontophoretic delivery of antimicrobials’, Int J Electrochem Sci, vol. 9, no. 9, 2014, doi: 10.1016/s1452-3981(23)08151-8.
19. K. Ita, ‘Transdermal iontophoretic drug delivery: Advances and challenges’, 2016. doi: 10.3109/1061186X.2015.1090442.
20.        M. Singhal, C. E. S. Jimenez, M. Lapteva, and Y. N. Kalia, ‘Transdermal medical devices: Formulation aspects’, in Innovative Dosage Forms: Design and Development at Early Stage, 2019. doi: 10.1002/9783527812172.ch8.
21. P. S. Kumbhar et al., ‘Advances in Iontophoresis-Based Drug Delivery’, in Transdermal Applications of Minimally Invasive Drug Delivery Systems: Current Trends and Future Perspectives, 2025. doi: 10.1007/978-981-96-6275-3_3.
22. T. Y. Kim et al., ‘Smart contact lens systems for ocular drug delivery and therapy’, 2023. doi: 10.1016/j.addr.2023.114817.